CAS Number:910463-68-2
Molecular Formula:C187H291N45O59
Appearance:White to off-white lyophilized powder
Key Feature:Long half-life, once-weekly subcutaneous administration
Main Indications (Formulation Use)
- Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus
- Chronic weight management in adults with obesity or overweight with weight-related comorbidities
- Cardiovascular risk reduction in eligible diabetic patients
- Purity: ≥99.0% by HPLC, strict impurity control
- Manufactured under cGMP guidelines
- Full batch records and stability data available
- Suitable for injectable generic development
Store in tightly sealed containers, protected from light and moisture, at -20°C frozen conditions. Avoid repeated freeze-thaw cycles.
Frequently Asked Questions
Q: What is the purity level of this product?
A: The product maintains a high purity level of ≥99.0% as verified by HPLC analysis, ensuring strict control over impurities.
Q: What are the primary storage requirements?
A: It should be stored in a frozen environment at -20°C. It is crucial to keep the containers tightly sealed and protected from both light and moisture.
Q: For which clinical indications is this formulation typically used?
A: It is primarily used for glycemic control in type 2 diabetes, chronic weight management for obesity/overweight, and reducing cardiovascular risks in diabetic patients.
Q: Is this product suitable for pharmaceutical development?
A: Yes, it is manufactured under cGMP guidelines and is specifically suitable for injectable generic development, with full stability data available.
Q: What is the administration frequency of the final formulation?
A: Due to its long half-life, the resulting formulation is designed for once-weekly subcutaneous administration.
Q: Should I be concerned about freeze-thaw cycles?
A: Yes, to maintain the integrity and stability of the lyophilized powder, you should avoid repeated freeze-thaw cycles.
